• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Sapiens Reports Fourth Quarter 2023 Financial Results

    2/20/24 6:30:00 AM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology
    Get the next $SPNS alert in real time by email

    HOLON, Israel, Feb. 20, 2024 /PRNewswire/ -- Sapiens International Corporation, (NASDAQ:SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, today announced its financial results for the fourth quarter ended December 31, 2023.

    Sapiens International Corporation Logo

     

    Summary Results for Fourth Quarter 2023 (USD in millions, except per share data)



    GAAP



    Non-GAAP





    Q4 2023

    Q4 2022

    % Change

    Q4 2023

    Q4 2022

    % Change

    Revenue

    $130.9

    $119.5

    9.5 %

    $130.9

    $119.5

    9.6 %

    Gross Profit

    $55.9

    $50.3

    11.2 %

    $59.4

    $53.8

    10.4 %

    Gross Margin

    42.8 %

    42.1 %

     70 bps

    45.4 %

    45.0 %

    40 bps

    Operating Income

    $20.1

    $16.5

    21.9 %

    $24.2

    $21.1

    14.7 %

    Operating Margin

    15.4 %

    13.8 %

     160 bps

    18.4 %

    17.6 %

    80 bps

    Net Income (*)

    $17.0

    $13.4

    27.0 %

    $20.1

    $18.0

    11.4 %

    Diluted EPS

    $0.30

    $0.24

    25.0 %

    $0.36

    $0.32

    12.5 %

     

     

    Summary Results for Full Year end 2023 (USD in millions, except per share data)



    GAAP

    % Change

    Non-GAAP

    % Change



    2023

    2022



    2023

    2022



    Revenue

    $514.6

    $474.7

    8.4 %

    $514.8

    $474.8

    8.4 %

    Gross Profit

    $219.6

    $200.2

    9.7 %

    $233.0

    $213.5

    9.1 %

    Gross Margin

    42.7 %

    42.2 %

    50 bps

    45.3 %

    45.0 %

    30 bps

    Operating Income

    $78.9

    $66.5

    18.6 %

    $94.1

    $83.5

    12.8 %

    Operating Margin

    15.3 %

    14.0 %

    130 bps

    18.3 %

    17.6 %

    70 bps

    Net income (*)

    $62.4

    $52.6

    18.7 %

    $75.0

    $67.2

    11.7 %

    Diluted EPS

    $1.12

    $0.95

    17.9 %

    $1.35

    $1.21

    11.6 %



    (*) Attributable to Sapiens' shareholders

     

    Roni Al-Dor, President and CEO of Sapiens, stated, "In 2023, Sapiens executed its growth strategy across our regions and product lines, achieving an 8.4% growth in non-GAAP revenue and bolstering non-GAAP operating profit by an impressive 12.8%. Our ARR in the fourth quarter was $164.8 million, a growth of 13.5% compared to the fourth quarter of 2022.

    Our North American and European businesses have shown robust growth, and we are well-positioned to sustain growth in these markets in 2024. We completed multiple successful go-lives globally and demonstrated noteworthy expansion of our market share by signing about 30 new deals with both new and existing customers across core, Data, digital, and cloud in P&C, Workers' Comp, Life, and Reinsurance. Furthermore, we anticipate continued momentum and growth with new logos and cross-selling opportunities within our existing accounts across all regions throughout 2024."

    "Key initiatives that will guide our strategic direction in 2024 include our continued transition to SaaS with all our products, with our evolved Sapiens Insurance Platform, an end-to-end integrated business-led SaaS platform with advanced technology and data capabilities," continued Mr. Al-Dor. "In North America, EMEA, and APAC, we are increasing our headcount across sales, marketing, and product marketing to drive success. We remain focused on further expansion in North America, leveraging our investments in the region, and increasing our market share in Europe where we have a strong footprint."

    "We are introducing 2024 guidance for non-GAAP revenue in a range of $550 million to $555 million, and non-GAAP operating margin in a range of 18.1% to 18.5%," concluded Mr. Al-Dor.

    Quarterly Results Conference Call

    Management will host a conference call and webcast on February 20, 2024, at 9:30 a.m. Eastern Time (4:30 p.m. in Israel) to review and discuss Sapiens' results. Please call the following numbers (at least 10 minutes before the scheduled time) to participate:

    North America (toll-free): 1-888-642-5032

    International: 972-3-9180609

    UK: 0-800-917-5108

    The live webcast of the call can be viewed on Sapiens' website at: https://www.sapiens.com/investor-relations/ir-events-presentations. A replay of the call will be available one business day following the completion of the event, at the same link for 90 days.

    Non-GAAP Financial Measures

    This press release contains the following non-GAAP financial measures: non-GAAP revenue, ARR, non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating income, non-GAAP operating margin, non-GAAP net income attributed to Sapiens shareholders, non-GAAP basic and diluted earnings per share, Adjusted EBITDA and Adjusted Free Cash-Flow.

    Sapiens believes that these non-GAAP measures of financial results provide useful information to management and investors regarding certain financial and business trends relating to Sapiens' financial condition and results of operations. The Company's management uses these non-GAAP measures to compare the Company's performance to that of prior periods for trend analyses, for purposes of determining executive and senior management incentive compensation and for budgeting and planning purposes. These measures are used in financial reports prepared for management and in quarterly financial reports presented to the Company's board of directors. The Company believes that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating ongoing operating results and trends, and in comparing the Company's financial measures with other software companies, many of which present similar non-GAAP financial measures to investors.

    Non-GAAP financial measures consist of GAAP financial measures adjusted to exclude: Valuation adjustment on acquired deferred revenue, amortization of capitalized software development and other intangible assets, capitalization of software development, stock-based compensation, compensation related to acquisition and acquisition-related costs, restructuring and cost reduction costs, and tax adjustments related to non-GAAP adjustments.

    Management of the Company does not consider these non-GAAP measures in isolation, or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of these non-GAAP financial measures is that they exclude significant expenses and income that are required by GAAP to be recorded in the Company's financial statements. In addition, they are subject to inherent limitations, as they reflect the exercise of judgment by management about which expenses and income are excluded or included in determining these non-GAAP financial measures.

    To compensate for these limitations, management presents non-GAAP financial measures in connection with GAAP results. Sapiens urges investors to review the reconciliation of its non-GAAP financial measures to the comparable GAAP financial measures, which it includes in press releases announcing quarterly financial results, including this press release, and not to rely on any single financial measure to evaluate the Company's business.

    Reconciliation tables of the most comparable GAAP financial measures to the non-GAAP financial measures used in this press release are included with the financial tables of this release.

    The Company defines Annual Recurring Revenue ("ARR") as the annualized value of our revenue from customer subscriptions, term licenses, maintenance, application maintenance, and cloud solutions. The ARR run rate is equal to the product of (i) the sum of these revenues in our most recently completed fiscal quarter, multiplied by (ii) four.

    The Company defines Adjusted EBITDA as net profit, adjusted to eliminate valuation adjustment on acquired deferred revenue, stock-based compensation expense, depreciation and amortization, capitalization of software development costs, compensation expenses related to acquisition and acquisition-related costs, restructuring and cost reduction costs, financial expense (income), provision for income taxes and other income (expenses). These amounts are often excluded by other companies as well, in order to help investors understand the operational performance of their business.

    The Company uses Adjusted EBITDA as a measurement of its operating performance, because it assists in comparing the operating performance on a consistent basis by removing the impact of certain non-cash and non-operating items. Adjusted EBITDA reflects an additional way of viewing aspects of the operations that the Company believes, when viewed with the GAAP results and the accompanying reconciliations to corresponding GAAP financial measures, provide a more complete understanding of factors and trends affecting its business. The Company uses Adjusted Free Cash-Flow as a measurement of its operating performance, and reconciles cash-flow from operating activities to Adjusted Free Cash-Flow, while reducing the amounts for capitalization of software development costs and capital expenditures. The Company adds back cash payments made for former acquisitions in respect of future performance targets and retention criteria as determined upon acquisition date of the respective acquired company, which were included in the cash-flow from operating activities. We believe that Adjusted Free Cash-Flow is useful in evaluating our business, because Adjusted Free Cash-Flow reflects the cash surplus available to fund the expansion of our business.

    About Sapiens

    Sapiens International Corporation (NASDAQ and TASE: SPNS) empowers the financial sector, with a focus on insurance, to transform and become digital, innovative and agile. Backed by more than 40 years of industry expertise, Sapiens offers a complete insurance platform, with pre-integrated, low-code solutions and a cloud-first approach that accelerates customers' digital transformation. Serving over 600 customers in 30 countries, Sapiens offers insurers across property and casualty, workers compensation and life markets the most comprehensive set of solutions, from core to complementary, including Reinsurance, Financial & Compliance, Data & Analytics, Digital, and Decision Management.  For more information visit www.sapiens.com or follow us on LinkedIn.

     

    Investor and Media Contact

     

    Yaffa Cohen-Ifrah

    Chief Marketing Officer and Head of

    Investor Relations, Sapiens

    [email protected]

    +1 917-533-4782

     

    Investors Contact

     

    Kimberly Rogers

    Managing Director, Hayden IR

    +1 541-904-5075

    [email protected]

     





     

    Forward Looking Statements

    Certain matters discussed in this press release that are incorporated herein by reference are forward-looking statements within the meaning of Section 27A of the Securities Act, Section 21E of the Exchange Act and the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, that are based on our beliefs, assumptions and expectations, as well as information currently available to us. Such forward-looking statements may be identified by the use of the words "anticipate," "believe," "estimate," "expect," "may," "will," "plan" and similar expressions. Such statements reflect our current views with respect to future events and are subject to certain risks and uncertainties. There are important factors that could cause our actual results, levels of activity, performance or achievements to differ materially from the results, levels of activity, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to: the degree of our success in our plans to leverage our global footprint to grow our sales; the degree of our success in integrating the companies that we have acquired through the implementation of our M&A growth strategy; the lengthy development cycles for our solutions, which may frustrate our ability to realize revenues and/or profits from our potential new solutions; our lengthy and complex sales cycles, which do not always result in the realization of revenues; the degree of our success in retaining our existing customers or competing effectively for greater market share; difficulties in successfully planning and managing changes in the size of our operations; the frequency of the long-term, large, complex projects that we perform that involve complex estimates of project costs and profit margins, which sometimes change mid-stream; the challenges and potential liability that heightened privacy laws and regulations pose to our business; occasional disputes with clients, which may adversely impact our results of operations and our reputation; various intellectual property issues related to our business; potential unanticipated product vulnerabilities or cybersecurity breaches of our or our customers' systems; risks related to the insurance industry in which our clients operate; risks associated with our global sales and operations, such as changes in regulatory requirements, wide-spread viruses and epidemics like the recent novel coronavirus pandemic, which adversely affected our results of operations, or fluctuations in currency exchange rates; and risks related to our principal location in Israel and our status as a Cayman Islands company. While we believe such forward-looking statements are based on reasonable assumptions, should one or more of the underlying assumptions prove incorrect, or these risks or uncertainties materialize, our actual results may differ materially from those expressed or implied by the forward-looking statements. Please read the risks discussed under the heading "Risk Factors" in our most recent Annual Report on Form 20-F, in order to review conditions that we believe could cause actual results to differ materially from those contemplated by the forward-looking statements. You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that future results, levels of activity, performance and events and circumstances reflected in the forward-looking statements will be achieved or will occur. Except as required by law, we undertake no obligation to update publicly any forward-looking statements for any reason, to conform these statements to actual results or to changes in our expectations.

                 

     

    SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES          



    CONDENSED CONSOLIDATED STATEMENT OF INCOME      

    U.S. dollars in thousands (except per share amounts)









      Three months ended



    Year ended







     December 31,



     December 31,







    2023



    2022



    2023



    2022







     (unaudited)



     (unaudited)



     (unaudited)



     (unaudited)





















     Revenue



    130,859



    119,463



    514,584



    474,736

     Cost of revenue



    74,910



    69,158



    294,990



    274,573





















     Gross profit



    55,949



    50,305



    219,594



    200,163





















     Operating expenses:



















     Research and development, net



    16,084



    15,251



    63,475



    58,656



     Selling, marketing, general and administrative



    19,776



    18,573



    77,251



    75,016

     Total operating expenses



    35,860



    33,824



    140,726



    133,672





















     Operating income



    20,089



    16,481



    78,868



    66,491





















     Financial and other expenses (income), net



    (560)



    (1,097)



    1,750



    941

     Taxes on income



    3,624



    4,276



    14,251



    12,619









































     Net income



    17,025



    13,302



    62,867



    52,931





















     Attributable to non-controlling interest



    52



    (65)



    423



    336





















     Net income attributable to Sapiens' shareholders



    16,973



    13,367



    62,444



    52,595









































     Basic earnings per share



    0.30



    0.24



    1.13



    0.95





















     Diluted earnings per share



    0.30



    0.24



    1.12



    0.95







































    Weighted average number of shares outstanding used to

     compute basic earnings per share (in thousands)



    55,733



    55,140



    55,372



    55,117



















    Weighted average number of shares outstanding used to

     compute diluted earnings per share (in thousands)



    55,910



    55,521



    55,721



    55,570

     

     

    SAPIENS INTERNATIONAL CORPORATION N.V. AND SUBSIDIARIES 



    RECONCILIATION OF GAAP TO NON-GAAP RESULTS

    U.S. dollars in thousands (except per share amounts)







    Three months ended



    Year ended





    December 31,



    December 31,





    2023



    2022



    2023



    2022





    (unaudited)



    (unaudited)



    (unaudited)



    (unaudited)



















    GAAP revenue



    130,859



    119,463



    514,584



    474,736

    Valuation adjustment on acquired deferred revenue



    55



    23



    220



    92

    Non-GAAP revenue



    130,914



    119,486



    514,804



    474,828



















    GAAP gross profit



    55,949



    50,305



    219,594



    200,163

    Revenue adjustment



    55



    23



    220



    92

    Amortization of capitalized software



    1,501



    1,517



    5,775



    5,840

    Amortization of other intangible assets



    1,865



    1,929



    7,396



    7,375

    Non-GAAP gross profit



    59,370



    53,774



    232,985



    213,470



















    GAAP operating income



    20,089



    16,481



    78,868



    66,491

    Gross profit adjustments



    3,421



    3,469



    13,391



    13,307

    Capitalization of software development



    (1,543)



    (1,238)



    (6,518)



    (6,097)

    Amortization of other intangible assets



    1,169



    1,115



    4,403



    4,783

    Stock-based compensation



    698



    759



    3,658



    3,960

    Acquisition-related costs (*)



    318



    472



    339



    1,033

    Non-GAAP operating income



    24,152



    21,058



    94,141



    83,477



















      GAAP net income attributable to Sapiens' shareholders



    16,973



    13,367



    62,444



    52,595

      Operating income adjustments



    4,063



    4,577



    15,273



    16,986

      Taxes on income



    (955)



    78



    (2,693)



    (2,411)

      Non-GAAP net income attributable to Sapiens' shareholders



    20,081



    18,022



    75,024



    67,170



















     (*) Acquisition-related costs pertain to charges on behalf of M&A agreements related to future performance targets and

     retention criteria, as well as third-party services, such as tax, accounting and legal rendered until the acquisition date.

     

     

    Adjusted EBITDA Calculation

    U.S. dollars in thousands







    Three months ended



    Year ended





     December 31,



     December 31,





    2023



    2022



    2023



    2022



















    GAAP operating profit



    20,089



    16,481



    78,868



    66,491



















    Non-GAAP adjustments:

















    Valuation adjustment on acquired deferred revenue



    55



    23



    220



    92

    Amortization of capitalized software



    1,501



    1,517



    5,775



    5,840

    Amortization of other intangible assets



    3,034



    3,044



    11,799



    12,158

    Capitalization of software development



    (1,543)



    (1,238)



    (6,518)



    (6,097)

    Stock-based compensation



    698



    759



    3,658



    3,960

    Compensation related to acquisition and

     acquisition-related costs



    318



    472



    339



    1,033



















    Non-GAAP operating profit



    24,152



    21,058



    94,141



    83,477



















    Depreciation



    1,115



    1,034



    3,865



    4,242



















    Adjusted EBITDA



    25,267



    22,092



    98,006



    87,719





































     

     

    Summary of NON-GAAP Financial Information 

    U.S. dollars in thousands (except per share amounts)





    Q4 2023



    Q3 2023



    Q2 2023



    Q1 2023



    Q4 2022





















    Revenues

    130,914



    130,760



    128,354



    124,776



    119,486

    Gross profit

    59,370



    59,260



    57,992



    56,363



    53,774

    Operating income

    24,152



    24,058



    23,417



    22,514



    21,058

    Adjusted EBITDA

    25,267



    24,777



    24,393



    23,569



    22,092

    Net income to Sapiens' shareholders

    20,081



    19,080



    18,610



    17,253



    18,022





















    Diluted earnings per share

    0.36



    0.34



    0.33



    0.31



    0.32

     

     

    Non-GAAP Revenues by Geographic Breakdown

    U.S. dollars in thousands





    Q4 2023



    Q3 2023



    Q2 2023



    Q1 2023



    Q4 2022





















    North America

    54,882



    54,848



    52,116



    50,371



    50,801

    Europe

    65,239



    64,662



    62,960



    64,572



    56,910

    Rest of the World

    10,793



    11,250



    13,278



    9,833



    11,775





















    Total

    130,914



    130,760



    128,354



    124,776



    119,486

     

     

    Non-GAAP Revenue breakdown











    U.S. dollars in thousands















    Three months ended



    Year ended





    December 31,



    December 31,





    2023



    2022



    2023



    2022





















    Software products and re-occurring post-production services (*)

    90,399



    77,702



    342,156



    300,241



    Pre-production implementation services (**)

    40,515



    41,784



    172,648



    174,587





















    Total Revenues

    130,914



    119,486



    514,804



    474,828



























































    Three months ended



    Year ended





    December 31,



    December 31,





    2023



    2022



    2023



    2022





















    Software products and re-occurring post-production services (*)

    48,815



    42,120



    182,154



    161,534



    Pre-production implementation services (**)

    10,555



    11,654



    50,831



    51,936





















    Total Gross profit

    59,370



    53,774



    232,985



    213,470









































    Three months ended



    Year ended





    December 31,



    December 31,





    2023



    2022



    2023



    2022





















    Software products and re-occurring post-production services (*)

    54.00 %



    54.20 %



    53.20 %



    53.80 %



    Pre-production implementation services (**)

    26.10 %



    27.90 %



    29.40 %



    29.70 %





















    Gross Margin

    45.40 %



    45.00 %



    45.30 %



    45.00 %





















    (*) Software products and re-occurring post-production services include mainly subscription, term license, maintenance, application maintenance, cloud solutions,and post-production services. This revenue stream is a mix of recurring and re-occurring in nature. 

    (**) Pre-production implementation services include mainly implementation services before go-live, which are one-time in nature.

     

    Annual Recurring Revenue ("ARR")

    U.S. dollars in thousands

     

    Three months ended

    December 31,

    2023



    2022

    164,840



    145,188

     

     

    Adjusted Free Cash-Flow

    U.S. dollars in thousands





    Q4 2023



    Q3 2023



    Q2 2023



    Q1 2023



    Q4 2022





















    Cash-flow from operating activities

    38,646



    3,988



    14,603



    22,188



    14,430

    Increase in capitalized software development costs

    (1,543)



    (1,638)



    (1,679)



    (1,658)



    (1,238)

    Capital expenditures

    (421)



    (696)



    (775)



    (634)



    (400)

    Free cash-flow

    36,682



    1,654



    12,149



    19,896



    12,792





















    Cash payments attributed to acquisition-related costs(*) (**)

    221



    -



    -



    30



    1,100





















    Adjusted free cash-flow

    36,903



    1,654



    12,149



    19,926



    13,892



    (*) Included in cash-flow from operating activities

    (**) Acquisition-related payments pertain to payments on behalf of M&A agreements related to future performance targets and

     retention criteria, as well as third-party services, such as, tax, accounting and legal rendered until the acquisition date.

     

     

    SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES



    CONDENSED CONSOLIDATED BALANCE SHEET

    U.S. dollars in thousands









    December 31,



    December 31,







    2023



    2022







     (unaudited)



     (unaudited)













     ASSETS























     CURRENT ASSETS











    Cash and cash equivalents



    126,716



    160,285



    Short-term bank deposit



    75,400



    20,000



    Trade receivables, net and unbilled receivables



    90,273



    93,382



    Other receivables and prepaid expenses



    22,514



    11,640



    Total current assets



    314,903



    285,307













     LONG-TERM ASSETS











    Property and equipment, net



    12,661



    12,021



    Severance pay fund



    3,605



    3,996



    Goodwill and intangible assets, net



    317,352



    319,661



    Operating lease right-of-use assets



    23,557



    33,688



    Other long-term assets



    17,546



    13,671



    Total long-term assets



    374,721



    383,037













     TOTAL ASSETS



    689,624



    668,344













    LIABILITIES AND EQUITY





















     CURRENT LIABILITIES











    Trade payables



    6,291



    9,415



    Current maturities of Series B Debentures



    19,796



    19,796



    Accrued expenses and other liabilities



    77,873



    76,962



    Current maturities of operating lease liabilities



    6,623



    9,063



    Deferred revenue



    38,541



    30,720



    Total current liabilities



    149,124



    145,956













     LONG-TERM LIABILITIES











    Series B Debentures, net of current maturities



    39,543



    59,275



    Deferred tax liabilities



    10,820



    11,363



    Other long-term liabilities



    11,538



    13,312



    Long-term operating lease liabilities



    21,084



    28,432



    Redeemable non-controlling interest



    -



    89



    Accrued severance pay



    7,568



    7,063



    Total long-term liabilities



    90,553



    119,534













    EQUITY





    449,947



    402,854













    TOTAL LIABILITIES AND EQUITY



    689,624



    668,344











     

     

    SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES



    CONSOLIDATED STATEMENT OF CASH FLOW

    U.S. dollars in thousands





    For the Twelve months ended

    December 31,



    2023



    2022



    (unaudited)



    (unaudited)

    Cash flows from operating activities:







    Net income

    62,867



    52,931

    Reconciliation of net income to net cash provided by operating activities:







    Depreciation and amortization

    21,439



    22,240

    Accretion of discount on Series B Debentures

    64



    85

    Capital loss from sale of property and equipment

    195



    26

    Stock-based compensation related to options issued to employees

    3,658



    3,960









    Net changes in operating assets and liabilities, net of amount acquired:







    Decrease (increase) in trade receivables, net and unbilled receivables

    3,960



    (21,860)

    Decrease in deferred tax liabilities, net

    (3,003)



    (10,134)

    Decrease (increase) in other operating assets

    (5,402)



    7,729

    Increase (decrease) in trade payables

    (3,580)



    4,634

    Decrease in other operating liabilities

    (8,948)



    (8,171)

    Increase (decrease) in deferred revenues

    7,266



    (7,738)

    Increase in accrued severance pay, net

    909



    78

    Net cash provided by operating activities

    79,425



    43,780









    Cash flows from investing activities:















    Purchase of property and equipment

    (2,574)



    (2,757)

    Proceeds from (investments in) deposits

    (55,499)



    26

    Proceeds from sale of property and equipment

    48



    54

    Payments for business acquisitions, net of cash acquired

    (8,060)



    (3,466)

    Capitalized software development costs

    (6,518)



    (6,097)

    Acquisition of intellectual property

    (177)



    (200)

    Net cash used in investing activities

    (72,780)



    (12,440)









    Cash flows from financing activities:







    Proceeds from employee stock options exercised

    4,809



    -

    Distribution of dividend

    (28,144)



    (38,579)

    Repayment of Series B Debenture

    (19,796)



    (19,796)

    Acquisition of non-controlling interests

    (161)



    -

    Dividend to non-controlling interest

    (47)



    -

    Net cash used in financing activities

    (43,339)



    (58,375)









    Effect of exchange rate changes on cash and cash equivalents

    3,125



    (2,923)









    Decrease in cash and cash equivalents

    (33,569)



    (29,958)

    Cash and cash equivalents at the beginning of period

    160,285



    190,243









    Cash and cash equivalents at the end of period

    126,716



    160,285

     

     

    Debentures Covenants

    As of December 31, 2023, Sapiens was in compliance with all of its financial covenants under the indenture for the Series B Debentures, based on having achieved the following in its consolidated financial results:

    Covenant 1 

    • Target shareholders' equity (excluding non-controlling interest): above $120 million.
    • Actual shareholders' equity (excluding non-controlling interest) equal to $447.3 million.

    Covenant 2

    • Target ratio of net financial indebtedness to net capitalization (in each case, as defined under the indenture for the Company's Series B Debentures) below 65%.
    • Actual ratio of net financial indebtedness to net capitalization equal to (46.48)%.

    Covenant 3

    • Target ratio of net financial indebtedness to EBITDA (accumulated calculation for the four last quarters) is below 5.5.
    • Actual ratio of net financial indebtedness to EBITDA (accumulated calculation for the four last quarters) is equal to (1.46).

    Logo - http://mma.prnewswire.com/media/585787/Sapiens_Logo.jpg

     

    Cision View original content:https://www.prnewswire.com/news-releases/sapiens-reports-fourth-quarter-2023-financial-results-302065964.html

    SOURCE Sapiens International Corporation

    Get the next $SPNS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SPNS

    DatePrice TargetRatingAnalyst
    2/3/2025$36.00 → $28.00Buy → Hold
    Jefferies
    5/5/2023$24.00Equal Weight → Underweight
    Barclays
    1/23/2023$28.00Buy
    Goldman
    12/1/2022$20.00Underweight
    JP Morgan
    2/24/2022$38.00 → $30.00Buy
    Citigroup
    2/24/2022$40.00 → $36.00Buy
    Needham
    12/14/2021Neutral → Underweight
    JP Morgan
    12/14/2021$35.00Neutral → Underweight
    JP Morgan
    More analyst ratings

    $SPNS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Sapiens Int'l downgraded by Jefferies with a new price target

    Jefferies downgraded Sapiens Int'l from Buy to Hold and set a new price target of $28.00 from $36.00 previously

    2/3/25 7:11:09 AM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology

    Sapiens Int'l downgraded by Barclays with a new price target

    Barclays downgraded Sapiens Int'l from Equal Weight to Underweight and set a new price target of $24.00

    5/5/23 7:20:13 AM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology

    Goldman initiated coverage on Sapiens Int'l with a new price target

    Goldman initiated coverage of Sapiens Int'l with a rating of Buy and set a new price target of $28.00

    1/23/23 7:48:42 AM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology

    $SPNS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Sapiens Announces Leadership Appointments Following Closing of Acquisition by Advent

    Acquisition supports Sapiens' long-term growth, innovation and global expansionAfter twenty years leading Sapiens, Roni Al-Dor has decided to step down as CEO and PresidentNew leadership appointments to support the next phase of transformationLONDON, Dec. 17, 2025 /PRNewswire/ -- Sapiens International Corporation N.V. ("Sapiens") today announces a series of senior leadership appointments that will support the company's next phase of transformation and global growth. These appointments follow the successful closing of Sapiens' acquisition by Advent, a leading global private equity investor. The transaction was first announced on August 13, 2025, was approved by Sapiens shareholders at the Ext

    12/17/25 12:34:00 PM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology

    Sapiens Reports Third Quarter 2025 Financial Results

    ROCHELLE PARK, N.J., Nov. 13, 2025 /PRNewswire/ -- Sapiens International Corporation, (NASDAQ:SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, today announced its financial results for the third quarter ended September 30, 2025. Summary Results for Third Quarter 2025 (USD in millions, except per share data) GAAP Non-GAAP Q3 2025 Q3 2024  % Change Q3 2025 Q3 2024 % Change Revenue $ 152.3 $ 137.0 11.2 % $ 152.3 $ 137.0 11.2 % Gross Profit $ 67.3 $ 60.3 11.6 % $ 70.7 $ 62.8 12.5 % Gross Margin 44.2 % 44.0 %  20 bps 46.4 % 45.8 % 60 bps Operating Income $ 17.8 $ 21.7 -18.3 % $ 25.5 $ 25.1 1.5 % Operating Margin 11.7 % 15.9 %  -420 bps 16.7 % 18.3

    11/13/25 5:35:00 AM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology

    SAPIENS TO ANNOUNCE THIRD QUARTER 2025 FINANCIAL RESULTS ON NOVEMBER 13, 2025

    ROCHELLE PARK, N.J., Nov. 6, 2025 /PRNewswire/ -- Sapiens International Corporation (NASDAQ:SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, announced today that it will report its financial results for the Third quarter of 2025 on Thursday November 13, 2025. On August 12, 2025, Sapiens announced that it entered into a definitive agreement to be acquired by Advent, a leading global private equity investor, for $43.50 per common share in cash, valuing Sapiens at approximately $2.5 billion. About SapiensSapiens International Corporation (NASDAQ:SPNS) (TASE: SPNS) is a global leader in intelligent SaaS-based software solutions. With Sapiens' robus

    11/6/25 7:40:00 AM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology

    $SPNS
    SEC Filings

    View All

    SEC Form S-8 POS filed by Sapiens International Corporation N.V.

    S-8 POS - SAPIENS INTERNATIONAL CORP N V (0000885740) (Filer)

    12/17/25 4:47:01 PM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology

    SEC Form S-8 POS filed by Sapiens International Corporation N.V.

    S-8 POS - SAPIENS INTERNATIONAL CORP N V (0000885740) (Filer)

    12/17/25 4:45:43 PM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology

    SEC Form S-8 POS filed by Sapiens International Corporation N.V.

    S-8 POS - SAPIENS INTERNATIONAL CORP N V (0000885740) (Filer)

    12/17/25 4:44:28 PM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology

    $SPNS
    Leadership Updates

    Live Leadership Updates

    View All

    Sapiens Announces Leadership Appointments Following Closing of Acquisition by Advent

    Acquisition supports Sapiens' long-term growth, innovation and global expansionAfter twenty years leading Sapiens, Roni Al-Dor has decided to step down as CEO and PresidentNew leadership appointments to support the next phase of transformationLONDON, Dec. 17, 2025 /PRNewswire/ -- Sapiens International Corporation N.V. ("Sapiens") today announces a series of senior leadership appointments that will support the company's next phase of transformation and global growth. These appointments follow the successful closing of Sapiens' acquisition by Advent, a leading global private equity investor. The transaction was first announced on August 13, 2025, was approved by Sapiens shareholders at the Ext

    12/17/25 12:34:00 PM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology

    Sapiens Appoints Jamie Yoder as North America President and General Manager

    HOLON, Israel, April 26, 2021 /PRNewswire/ -- Sapiens International Corporation, (NASDAQ:SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, today announced the appointment of Jamie Yoder as President and General Manager of Sapiens North America. Mr. Yoder's depth of leadership experience in the insurance and technology sectors, including senior management positions at top global professional services firms (such as PwC), will further strengthen Sapiens' footprint, strategy, and operations in North America and globally. Sapiens will benefit from his strong acumen across various touchpoints within the insurance life cycle, especially in these times

    4/26/21 9:58:00 AM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology

    $SPNS
    Financials

    Live finance-specific insights

    View All

    Sapiens Reports Third Quarter 2025 Financial Results

    ROCHELLE PARK, N.J., Nov. 13, 2025 /PRNewswire/ -- Sapiens International Corporation, (NASDAQ:SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, today announced its financial results for the third quarter ended September 30, 2025. Summary Results for Third Quarter 2025 (USD in millions, except per share data) GAAP Non-GAAP Q3 2025 Q3 2024  % Change Q3 2025 Q3 2024 % Change Revenue $ 152.3 $ 137.0 11.2 % $ 152.3 $ 137.0 11.2 % Gross Profit $ 67.3 $ 60.3 11.6 % $ 70.7 $ 62.8 12.5 % Gross Margin 44.2 % 44.0 %  20 bps 46.4 % 45.8 % 60 bps Operating Income $ 17.8 $ 21.7 -18.3 % $ 25.5 $ 25.1 1.5 % Operating Margin 11.7 % 15.9 %  -420 bps 16.7 % 18.3

    11/13/25 5:35:00 AM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology

    Sapiens Reports Second Quarter 2025 Financial Results

    ROCHELLE PARK, N.J., Aug. 13, 2025 /PRNewswire/ -- Sapiens International Corporation, (NASDAQ:SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, today announced its financial results for the second quarter ended June 30, 2025. Summary Results for Second Quarter 2025 (USD in millions, except per share data) GAAP Non-GAAP Q2 2025 Q2 2024 % Change Q2 2025 Q2 2024 % Change Revenue $141.6 $136.8 3.5 % $141.6 $136.8 3.5 % Gross Profit $61.9 $60.1 3.0 % $64.8 $62.5 3.8 % Gross Margin 43.7 % 43.9 %  -20 bps 45.8 % 45.7 % 10 bps Operating Income $16.8 $21.9 -23.2 % $23.1 $24.8 -7.1 % Operating Margin 11.9 % 16.0 %  -410 bps 16.3 % 18.2 % -190 bps Net Inc

    8/13/25 7:15:00 AM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology

    SAPIENS TO ANNOUNCE SECOND QUARTER 2025 FINANCIAL RESULTS ON AUGUST 13, 2025

    ROCHELLE PARK, N.J., July 23, 2025 /PRNewswire/ -- Sapiens International Corporation (NASDAQ:SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, announced today that it will report its financial results for the Second quarter of 2025 on Wednesday, August 13, 2025. Management will host a conference call and webcast on August 13, 2025, at 11:30 a.m. Eastern Time (6:30 p.m. in Israel) to review and discuss Sapiens' results. Please call the following numbers (at least 10 minutes before the scheduled time) to participate: North America (toll-free): 1-888-642-5032 International: 972-3-9180608 UK: 0-808-101-2717 The live webcast of the call can be access

    7/23/25 7:35:00 AM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology

    $SPNS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Sapiens International Corporation N.V. (Amendment)

    SC 13G/A - SAPIENS INTERNATIONAL CORP N V (0000885740) (Subject)

    1/17/23 6:12:29 AM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G/A filed by Sapiens International Corporation N.V. (Amendment)

    SC 13G/A - SAPIENS INTERNATIONAL CORP N V (0000885740) (Subject)

    7/28/22 6:03:57 AM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G/A filed by Sapiens International Corporation N.V. (Amendment)

    SC 13G/A - SAPIENS INTERNATIONAL CORP N V (0000885740) (Subject)

    2/7/22 6:08:41 AM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology